85 related articles for article (PubMed ID: 24682895)
1. Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer.
Lin XY; Zhang XP; Wu JH; Qiu XS; Wang EH
Tumour Biol; 2014 Jul; 35(7):6435-43. PubMed ID: 24682895
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer.
Wang Y; Dong Q; Zhang Q; Li Z; Wang E; Qiu X
Cancer Sci; 2010 May; 101(5):1279-85. PubMed ID: 20219076
[TBL] [Abstract][Full Text] [Related]
3. Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers.
Liang H; Xu Y; Zhao J; Chen M; Wang M
Cancer Gene Ther; 2024 May; 31(5):652-666. PubMed ID: 38499647
[TBL] [Abstract][Full Text] [Related]
4. Methylation‑associated inactivation of LATS1 and its effect on demethylation or overexpression on YAP and cell biological function in human renal cell carcinoma.
Chen KH; He J; Wang DL; Cao JJ; Li MC; Zhao XM; Sheng X; Li WB; Liu WJ
Int J Oncol; 2014 Dec; 45(6):2511-21. PubMed ID: 25270913
[TBL] [Abstract][Full Text] [Related]
5. Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability.
Qi Q; Li DY; Luo HR; Guan KL; Ye K
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7255-60. PubMed ID: 26039999
[TBL] [Abstract][Full Text] [Related]
6. The emerging roles of YAP and TAZ in cancer.
Moroishi T; Hansen CG; Guan KL
Nat Rev Cancer; 2015 Feb; 15(2):73-79. PubMed ID: 25592648
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer.
Yu T; Bachman J; Lai ZC
Protein Cell; 2015 Jan; 6(1):6-11. PubMed ID: 25482410
[TBL] [Abstract][Full Text] [Related]
8. Hippo pathway regulation of gastrointestinal tissues.
Yu FX; Meng Z; Plouffe SW; Guan KL
Annu Rev Physiol; 2015; 77():201-27. PubMed ID: 25293527
[TBL] [Abstract][Full Text] [Related]
9. The role of angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development.
Hirate Y; Sasaki H
Tissue Barriers; 2014 Jan; 2(1):e28127. PubMed ID: 24843842
[TBL] [Abstract][Full Text] [Related]
10. YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.
Lorenzetto E; Brenca M; Boeri M; Verri C; Piccinin E; Gasparini P; Facchinetti F; Rossi S; Salvatore G; Massimino M; Sozzi G; Maestro R; Modena P
Oncotarget; 2014 May; 5(9):2608-21. PubMed ID: 24810989
[TBL] [Abstract][Full Text] [Related]
11. Lung microRNAs Expression in Lung Cancer and COPD: A Preliminary Study.
Mirra D; Esposito R; Spaziano G; La Torre C; Vocca C; Tallarico M; Cione E; Gallelli L; D'Agostino B
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979715
[TBL] [Abstract][Full Text] [Related]
12. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein.
Zou J; Zhou L; Le Y; Fang Z; Zhong M; Nie F; Wei X; Zhang X; Chen Z; Cai L; Wang H; Xiong J; Fang Z; Xiang X
Cell Commun Signal; 2023 Feb; 21(1):38. PubMed ID: 36803368
[TBL] [Abstract][Full Text] [Related]
13. N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation.
Xu J; Shang Y; Qin X; Gai Y; Cai F; Xiao H; Zhou C; Fu Y; Ge X
Contrast Media Mol Imaging; 2022; 2022():1087622. PubMed ID: 35924072
[TBL] [Abstract][Full Text] [Related]
14. Hippo Signaling in the Endometrium.
Moon S; Hwang S; Kim B; Lee S; Kim H; Lee G; Hong K; Song H; Choi Y
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409214
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological and prognostic significances of LATS1 expression in breast cancer.
Zheng HC; Xiang LW; Cui ZG; Xue H; E Y; Zhao MZ
Histol Histopathol; 2022 Jul; 37(7):665-677. PubMed ID: 35142365
[TBL] [Abstract][Full Text] [Related]
16. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY
J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
[TBL] [Abstract][Full Text] [Related]
17. WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression.
Han Q; Rong X; Lin X; Zhang X; Fan C; Zhao H; Wang E
Cell Death Dis; 2021 Apr; 12(4):384. PubMed ID: 33837178
[TBL] [Abstract][Full Text] [Related]
18. Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population.
Goel H; Mathur R; Syeda S; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2021 Mar; 22(3):977-982. PubMed ID: 33773564
[TBL] [Abstract][Full Text] [Related]
19. Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancer.
Luo SY; Kwok HH; Yang PC; Ip MS; Minna JD; Lam DC
Transl Lung Cancer Res; 2020 Apr; 9(2):294-305. PubMed ID: 32420069
[TBL] [Abstract][Full Text] [Related]
20. LATS1 inhibits metastasis and epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
Wu J; Zhao Z; Zhang H; Kong F; Jiang H; Huang K; Zheng H
Int J Clin Exp Pathol; 2018; 11(4):2053-2063. PubMed ID: 31938312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
